Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anthogyr has a long-standing reputation for innovation in dental implantology. Its Axiom® implant system and INTEGRAL Guided Surgery Instrument Set are widely used for efficient, predictable clinical outcomes. The company focuses on simplifying clinical practice while improving patient comfort through advanced R&D and precision manufacturing. It operates globally with a strong presence in Europe and emerging markets such as China and Russia.
Clinical results are supported by decades of use, key opinion leader networks, and continuous product development.
Since its acquisition by the Straumann Group in 2019, Anthogyr has expanded its international reach while maintaining high standards for quality and innovation.
No specific drug pipeline exists as the company specializes in devices rather than therapeutics.
Pipeline breadth reflects multiple product lines within dental implants/prosthetics rather than traditional drug programs.
Notable products include the Axiom® range of dental implants/surgical solutions and CADCAM prosthetics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anthogyr.